Frontlight ResearchEarly access
TerminatedNo phase
Study With Dehisgel Used in Adult Patients Undergoing Colorectal Anastomosis
Key facts
- Who runs it
- Contipro Pharma a.s.
- Where
- Czechia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 20 people enrolled
- Started
- 23 Oct 2024
- Ended
- 30 Dec 2025
- Type of study
- Observational
- Record updated
- 24 March 2026
- Why it stopped
- safety was ok, but efficacy was considered too low - it was decided not to continue woth this study design
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age ≥ 18 years
- Patients with histologically confirmed rectal adenocarcinoma (< 15 cm from the anal margin) following rectal resection with colorectal anastomosis
- Patients with or without neoadjuvant therapy
- Patients willing and able to provide written informed consent
- Patients able to communicate effectively with the investigator in the local language and to understand and comply with the study requirements
Who cannot take part
- Subjects with known hypersensitivity or allergy to any component of the investigational product or to the administered antibiotics
- Acute surgery
- Other malignancies
- Age < 18 years
- Pregnant or breastfeeding women
- Patients in the terminal stage of life
- Preventive ostomy
- Incomplete data
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A two-phase, multicenter, open-label, "first-in-human" prospective study evaluating the product's safety and efficacy in a pivotal phase.
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multi-centre, Open-label, First-in-man Study With Dehisgel Used in Adult Patients Undergoing Colorectal Anastomosis Due to Rectal Cancer.
- Record updated
- 24 March 2026